2019
Insights in Hematology Conference

12-14 May, Cluj-Napoca, Romania

About Insights in Hematology

About The Event

The Insights in Hematology meeting, organized in the Transylvanian city of Cluj-Napoca was first organized in 2016 and it brought together highly cited international speakers in the field of hematology and stem cell transplantation in what is considered to be one of the most important hematology meeting organized in Eastern Europe. Insights in Hematology is one of the most interesting meetings in the Eastern European hematology and oncology landscape and is considered a great success in this part of Europe. While physicians and researchers in once behind the Iron Curtain have begun to adapt to the rigors of Western medicine and state-of-the-art protocols, both in clinical medicine as well as in basic and translational research, novel and performant medical research has been presented to the international community.

This edition of 2019 will take place in the "Lucian Blaga" Central University Library of Cluj-Napoca (2nd Clinicilor Street, Cluj-Napoca) and will attract well-known researchers and physicians, representing top medical centers in the United States, Japan, Israel, UK and Poland, that will present their high quality healthcare as well as top basic research.

Where

"Lucian Blaga" Central University Library of Cluj-Napoca, 2nd Clinicilor Street, Cluj-Napoca, Romania

When

Sunday to Tuesday
12-14 May 2019

20+ Speakers

Prestigious keynote speakers from the United States, Japan, Israel, UK and Poland will be presenting their latest research from universities and medical centers from all around the world. See the speaker list for more details.

450+ Participants

The audience will consist mostly of Senior Medical Students, Graduate Students, Medical Residents in Hematology or Oncology, Primary Hematologists and Oncologist as well as a variety of research staff and scientists.

Two Professional Certificates

By attending this meeting you will receive a diploma with 12 EMC Credits accredited by the Romanian College of Physicians and one by the Order of Biochemists, Biologists and Chemists in the Sanitary System in Romania also with 12 EMC Credits, which will be handed to you at the end of the conference.

Event Speakers

Speakers of the Insights in Hematology Conference

Speaker 1

Jerry L. Spivak

M.D., MACP

Dr. Spivak, Professor of Medicine and Oncology, is the Director of the Johns Hopkins Center for the Chronic Myeloproliferative Disorders. He is the author of over 250 publications and the recipient of a Research Career Development Award and a Merit Award from the National Institutes of Health.
Speaker 1

Gabriel Ghiaur

M.D., Ph.D.

Dr. Ghiaur, a member of the Johns Hopkins Kimmel Cancer Center, is a physician-scientist whose primary interest is normal and malignant hematopoiesis, especially the role of the microenvironment in stem cell biology. His research has translational potential in stem cell therapeutics, as well as acute leukemia.
Speaker 1

Stefan Ciurea

Assoc. Prof.

Associate Professor, Department of Stem Cell Transplantation

Dr. Ciurea is a hematologist in Houston, Texas and is affiliated with University of Texas MD Anderson Cancer Center. He received his medical degree from the University of Medicine and Pharmacy “Grigore T. Popa” Iasi and he has over 22 years of experience in hematology and internal medicine.
Speaker 1

Yoshihiro Inamoto

M.D.

Dr. Yoshihiro Inamoto is the medical director of the Department of Hematopoietic Stem Cell Transplantation at the National Center Hospital in Tokyo, Japan. He is also the Affiliate Investigator at the Fred Hutchinson Cancer Research Center in Seattle, USA. Dr. Inamoto has over 170 publications and his research themes are: Hematopoietic cell transplantation, Graft-versus-host disease, Late complication, Immunology and Microangiopathy.
Speaker 1

Shigeo Fuji

M.D., Ph.D.

Dr. Shigeo Fuji is the director of the Hematology Department at the Osaka International Cancer Institute in Osaka, Japan. Dr. Fuji has over 90 publications and in 2018 he received the JSHCT Working Group Research Award.
Speaker 1

Yoshiyuki Takahashi

M.D.

Dr. Yoshiyuki Takahashi was selected as a Professor and a Chairman in the department of Pediatrics in Nagoya University on Oct. 1, 2016. His profession is stem cell transplantation (SCT) and immunotherapy. Nagoya University Hospital is a stem cell transplantation center that performed the most transplants for children in Japan in 2015. Nagoya University Hospital was also officially selected as the best Childhood Cancer Center in Japan since 2013. He has been supported by the Japanese government grant to conduct a clinical trial of CD19-CAR-T cell therapy using non virus vector methods.
Speaker 1

David T. Teachey

M.D.

David T. Teachey, Associate Professor of Pediatrics Divisions of Hematology and Oncology Children’s Hospital of Philadelphia, is expertised in both oncology and hematology. His research is primarily focused on developing new therapies for children with white blood cell diseases, including ALL and a rare autoimmune disease called Autoimmune Lymphoproliferative Syndrome (ALPS). His research in ALL focuses on studying leukemic cells from children with high-risk disease.
Speaker 1

Melody Smith

M.D.

Melody Smith, assistent attending, was a fellow in Medical Hematology & Oncology at Memorial Sloan Kettering Cancer Center from 2012 to 2015 after which she joined the Adult Bone Marrow Transplant Service. Dr. Smith is also investigating approaches to optimize the administration of CD19 CAR T cells. This research has the potential to benefit patients, as it would be a strategy to decrease GVHD in allogeneic hematopoietic stem cell transplant recipients.
Speaker 1

Fanny Herisson

M.D., PhD.

Fanny Herisson is an instructor in Neurology at Massachusetts General Hospital and Harvard Medical School. Dr. Herisson is a physician and neuroscientist with a focus on cerebrovascular diseases, immunology and preclinical models.
Speaker 1

Yvonne Y.Chen

PhD.

Dr. Yvonne Chen is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at the University of California, Los Angeles. The Chen Laboratory focuses on applying synthetic biology and biomolecular engineering techniques to the development of novel mammalian-cell systems, particularly cell-based immunotherapy for cancer. Yvonne earned her Ph.D. in Chemical Engineering from the California Institute of Technology, and completed postdoctoral training at the Center for Childhood Cancer Research within the Seattle Children’s Research Institute, and at the Department of Systems Biology at Harvard Medical School. She received her B.S. in Chemical Engineering from Stanford University.
Speaker 1

Carlo M. Croce

M.D.

Dr. Croce, Professor of medicine at the Ohio State University, is one of the most cited scientists in the world with an H index of 220 and the most cited Italian scientist ever. His woek has been cited more than 220,000 times. Dr. Croce received numerous awards, including the 2006 Clowes Memorial Award from the American Association for Cancer Research for his discoveries of the molecular mechanisms of leukemia.
Speaker 1

Ivan Borrello

M.D.

Dr. Borello is an associate professor of oncology at the Johns Hopkins University School of Medicine and director of the Cell Therapy and cGMP Biologics Core for the Johns Hopkins Kimmel Cancer Center. Dr. Borrello's clinical research interest is in developing immune based therapies for the treatment of multiple myeloma.
Speaker 1

Joanna Zdziarska

M.D., Ph.D

Joanna Zdziarska, MD, PhD, is working at the Hematology Departmentof the University Hospital in Kraków, Poland, since October 2003. She is an internal diseases and hematology specialist. Since 2015 she is responsible for diagnosis and management of inherited and acquired bleeding disorders. Her doctoral thesis at the Jagiellonian University in Kraków granted a distinction (2017). Since 2008 she is a member of the Working Group for Hemostasis of the Polish Hematology and Transfusion Medicine Association. She has published 38 articles (16 as first author), 5 book chapters and 30 posters (17 as first author) on the topic of inherited and acquired bleeding disorders. She closely collaborates with the Polish Hemophilia Society.
Speaker 1

Daniel R. Couriel

M.D.

Dr. Couriel received his M.D. degree in 1987 at the Universidad de Buenos Aires in Argentina. His research interests are associated with new treatments and biomarkers for acute and chronic graft-versus-host disease. He serves on the Editorial Board of the Biology of Blood and Marrow Transplantation journal and in addition he co-chairs the GVHD subcommittee for the CIBMTR, and the Ancillary and Supportive Care committee of a NIH Consensus Project on Chronic GVHD.
Speaker 1

Roi Gazit

M.D., Ph.D.

Dr. Gazit studied at Hebrew University of Jerusalem for his B.Sc., M.Sc., and Ph.D.. For his doctorate, he studied the role of natural killer cells, in vivo with Professor Mandelboim Ofer. Currently, Dr. Gazit is working on the identification of HSC-specific genes within the hematopoietic system using microarray expression profiles; generation of mouse models for HSC-specific reporter and for the study of HSCs; and reprogramming of adult hematopoietic cells into HSC-state using multiple-gene lentivirus transduction into primary cells.
Speaker 1

Erik Aerts

 

Erik Aerts is President of the Hematology Nurses & Healthcare Professionals Group (HNHCP). In November, 2005, he developed and led the first Haematology-Oncology Nursing module in Switzerland, which supports nurses and gives them the opportunity to specialise in the field of haematology. He is currently involved in organising and teaching educational study days for several hematology and oncology projects.
Speaker 1

Alina Tanase

M.D.

Dr. Alina Tanase is head of the Bone marrow Transplantation Unit at the Fundeni Clinical Institute with expertise in hematology, pediatrics and clinical immunolgy. She was the manager of a postdoctoral research scholarship in a POSDRU 2010-2013 grant entitled “Supporting research by forming highly trained specialists during postdoctoral research”. Dr. Alina Tanase has published several internationally peer-reviewed papers in important journals such as Leukemia, the Lancet Oncology or Transplantation Proceedings.
Speaker 1

Ciprian Tomuleasa

M.D.

Dr. Ciprian Tomuleasa is the Congress Director of Insights in Hematology Conference. Dr. Tomuleasa is a young physician-scientiest that is currently affiliated with the Ion Chiricuță Clinical Cancer Center and Iuliu Hațieganu University of Medicine and Pharmacy Cluj Napoca, Romania. He did part of his training as a postdoctoral fellow at the Johns Hopkins University in the department of medicine, division of GI, and his transplant rotations with Dr. Ciurea at the University of Texas MD Anderson Cancer Center. His current research regards the molecular mechanism of haematological malignancies and the translation of his knowledge in the clinical setting. He published 85 papers, was cited 600 times and has a Hirsch index of 16.
Speaker 1

Dominik Dytfeld

M.D., Ph.D.

Graduated with distinction from the Faculty of Medicine of the Medical University of Poznań in 2001. PhD degree in medical sciences awarded in 2007. Assistant Professor at the Department of Haematology and Bone Marrow Transplantation of the Medical University of Poznań since 2002. A pioneer in the use of proteomics in exploring the biology and resistance mechanisms of multiple myeloma. Dominik Dytfeld has provided active contribution to multiple clinical projects investigating the efficacy of novel myeloma therapies.
Speaker 1

Mihnea Zdrenghea

M.D.

Dr. Mihnea Zdrenghea is one of the most appreciated hematologists in Romania, with a significant backround in both medical and clinical research. Dr. Zdrenghea has completed his PhD in tumor immunology and is the author of more than 20 scientific papers, as well as an author to 6 books. He is an attending physician in hematology at the Oncology Institute “Prof. Dr. Ion Chiricuta” in Cluj-Napoca. The skills and qualification of him as a department leader reflect on the entire research team and it is apparent the the collaboration with partner investigators can be accomplished. The publications and extensive experience in cancer biology research, proven by his ongoing projects and previous results, recommend Dr. Zdrenghea for capably managing a professional team of researchers that have the potential of bringing new innovative results.
Speaker 1

Cristina Blag

M.D.

Dr. Cristina Blag is a pediatric oncologist and hematologist that is currently affiliated with the Pediatric Oncology and Hematology Department of The Emergency Hospital for Children and Iuliu Hațieganu University of Medicine and Pharmacy Cluj Napoca, Romania. She has over 20 years of experience in pediatric hematology and oncology with a special interest in coagulation disorders and transfusion therapy.
Speaker 1

Horia Bumbea

M.D., Ph.D.

Dr. Horia Bumbea is a senior consultant and the attending physician in laboratory medicine/professor of clinical hematology at the Carol Davila University of Medicine and Pharmacy from Bucharest, Romania, and at the top of the Romanian diagnostic hematology field. Dr. Bumbea has published more than 30 papers and co-authored 5 books. He has a PhD concerning hematological neoplasms and, besides this, possesses an important background in laboratory and genetic diagnosis of this pathology.

Conference Schedule

Here is our conference schedule

Official Opening

Brenden Legros

Jerry L. Spivak, M.D., MACP

Keynote Lecture - "Myeloproliferative Neoplasms: Fact and Fiction"

Hubert Hirthe

Registration & Coffee Break

Hubert Hirthe

Carlo Croce, MD, PhD

"Role of microRNA dysregulation in cancer"

Hubert Hirthe

Ivan Borrello, MD

"Marrow Infiltrating Lymphocytes: Properties and Therapeutic Applications"

Hubert Hirthe

Gabriel Ghiaur, MD, PhD

"Control of retinoic acid homeostasis promotes drug resistance in the bone marrow niche"

Hubert Hirthe

Ciprian Tomuleasa, MD

"We're solving a complex equation. Together!"

Brenden Legros

Coffee Break

Hubert Hirthe

Daniel Couriel, MD

"Chronic GVHD"

Horia Bumbea, MD, Conf. Univ.

"IGHV gene mutation status in CLL - key to improving risk stratification"

Hubert Hirthe

Dominik Dytfeld, MD, PhD

"Optimizing Multiple Myeloma Patients Treatment in the Era of Monoclonal Antibodies"

Brenden Legros

Lunch Break

Hubert Hirthe

Fanny Herisson, MD, PhD

"Local interactions between the skull bone marrow and the brain: a shortcut for the neuro-immune axis"

Hubert Hirthe

David Teachey, MD

"Immunotherapies for Acute Lymphoblastic Leukemia"

Hubert Hirthe

Mihnea Zdrenghea Tudor, MD

"Kyprolis – overall survival matters"

Symposium sustained by Amgen

Brenden Legros

Coffee Break

Hubert Hirthe

Mihnea Zdrenghea Tudor, MD

"One less concern - Primary prophylaxis of therapy-induced febrile neutropenia"

Cristina Blag, MD

"Hemlibra - a life changing solution"

Hubert Hirthe

Registration & Coffee Break

Hubert Hirthe

Yoshihiro Inamoto, MD, PhD

"East vs. West in GVHD approach"

Hubert Hirthe

Stefan Ciurea, MD

"Updates on Allogeneic Stem Cell Transplantation for ALL"

Ciprian Tomuleasa, MD

"Changing the treatment paradigm in acute leukemias"

Brenden Legros

Coffee Break

Hubert Hirthe

Shigeo Fuji, MD

"Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report"

Hubert Hirthe

Melody Smith, MD

"Preclinical and Clinical use of Donor CAR T cells"

Hubert Hirthe

Yvonne Y. Chen, MD

"Engineering Next-Generation CAR-T Cells For Cancer Immunotherapy"

Brenden Legros

Lunch Break

Hubert Hirthe

Roi Gazit

"Genes for normal and malignant Hematopoietic Stem Cells"

Hubert Hirthe

Joanna Zdziarska, MD, PhD

"Management of a haemophilia patient"

Hubert Hirthe

Erik Aerts, Nurse Manager

"Nursing Challenges in Immunotherapy and Stem Cell Therapy"

Hubert Hirthe

Yoshiyuki Takahashi, MD

"Chimeric antigen receptor (CAR) T cell therapy with non-virus vector system"

Brenden Legros

Coffee Break

Hubert Hirthe

Alina Tanase, MD

"Opdivo Treatment in Hodgkin Lymphoma"

Hubert Hirthe

Alina Tanase, MD

"LEAM versus BEAM versus CLV for R/R lymphomas"

Hubert Hirthe

Ciprian Tomuleasa, MD

Closing Remarks

Event Venue

Event venue location info

"Lucian Blaga" Central University Library of Cluj-Napoca

Address: 2nd Clinicilor Street, Cluj-Napoca, Romania.

Organizers

Scientific Partners

Accreditation

Main Partners

Gold Partners

Bronze Partners

Silver Partners

Logistic Partners

Media Partners

20+

International speakers

450+

Participants

12

Hours of presentations and discussions

2

Days of networking

Sign up

The money collected from the event sign-up will be offered as a research grant to promising students after an open competition. More details will follow after the end of the event.

Students and Nurses
50 lei

  • Access to all scientific sessions
  • Diploma awarded by CMR with 12 CME Credits
  • Access to the expositional space organized by our sponsors
  • Participants welcome package
  • Possibility to network with other colleagues / renowned speakers / pharmaceutical representatives

Residents, PhD students, Pharmacists
100 lei

  • Access to all scientific sessions
  • Diploma awarded by CMR with 12 CME Credits
  • Access to the expositional space organized by our sponsors
  • Participants welcome package
  • Possibility to network with other colleagues / renowned speakers / pharmaceutical representatives

Physicians and scientists
200 lei

  • Access to all scientific sessions
  • Diploma awarded by CMR with 12 CME Credits
  • Access to the expositional space organized by our sponsors
  • Participants welcome package
  • Possibility to network with other colleagues / renowned speakers / pharmaceutical representatives

Contact Us

For any questions regarding the conference or the payment process please contact us using the form below.

Address

Str. Mircea Eliade, Nr 28, Et. 1, Ap. 11, Cluj-Napoca, Romania

Phone Number

+40 752 653 189